| mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
lapatinib |
FIMM |
pan-cancer |
AAC |
-0.027 |
0.9 |
| mRNA |
Bortezomib |
FIMM |
pan-cancer |
AAC |
-0.024 |
0.9 |
| mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
0.0087 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |